Afatinib Dimaleate Intermediate CAS 314771-76-1 Maʻemaʻe >99.0% (HPLC) Hale Hana
ʻO Ruifu Nā Kūwaena Hoʻolako Kimia o Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino)acetaldehyde Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H)-hoʻokahi CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineCAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl) oxy)quinazolin-4-AmineCAS 314771-88-5
Inoa Kimia | (S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine |
Nā huaʻōlelo like | N4-(3-Chloro-4-Fluorophenyl)-7-[[(3S)-Tetrahydro-3-Furanyl]oxy] -4,6-Quinazolinediamine;Afatinib haumia B;Afatinib-des(4-Dimethylamino-2-en-1-oxo)butyl;Des(4-Dimethylamino-2-en-1-oxo)butyl Afatinib |
Helu CAS | 314771-76-1 |
Helu CAT | RF-PI2028 |
Kūlana Kūʻai | Ma ka waihona, ka mana hana 100MT / makahiki |
ʻĀpana Molekala | C18H16ClFN4O2 |
Kaumaha Molecular | 374.8 |
Lae paila | 559.0±50.0℃ |
ʻO ka mānoanoa | 1.473±0.060 g/cm3 |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Melemele māmā i ka pauda melemele |
ʻIkepili | Pono ka Manawa Paʻa o ke Kiʻekiʻe Poʻokela ma HPLC e kūpono i ke kūlana |
Maʻemaʻe / Kaʻina Hanana | >99.0% (HPLC) |
Nalo ma ka maloo | <0.50% |
Koena ma ka Ignition | <0.20% |
Hoʻokahi haumia | <0.50% |
Huina paumaele | <1.00% |
Nā Metala Kaumaha (e like me Pb) | ≤20ppm |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | Waena o Afatinib Dimaleate (CAS: 850140-73-7) |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine (CAS: 314771-76-1) he mea waena o Afatinib Dimaleate (CAS: 850140-73-7).ʻO Afatinib ka lua o ka hanauna ikaika a hiki ʻole ke hoʻololi ʻia i nā mea hoʻopaneʻe ʻelua o ka epidermal growth factor receptor (EGFR) a me ke kanaka epidermal growth factor receptor 2 (HER2) tyrosine kinase, i hoʻomohala ʻia e Boehringer Ingelheim, Kelemānia.Hiki iā ia ke pale i ka hana o ka tyrosine kinase ma ke komo ʻana i ka hopena Michael me ka hui thiol o ka cysteine ma ke kūlana 797 o ka EGFR.Hana: 1. E like me Lapatinib a me Neratinib, ʻo Afatinib he mea hoʻopaneʻe kinase protein i hiki ʻole ke hoʻoneʻe i ke kanaka epidermal growth factor receptor 2 (Her2) a me ka epidermal growth factor receptor (EGFR) kinases.2. ʻAʻole ikaika wale ʻo Afatinib i nā hoʻololi EGFR i manaʻo ʻia e nā TKI o ka hanauna mua e like me erlotinib a i ʻole gefitinib, akā kūʻē pū kekahi i nā hoʻololi e like me T790M ʻaʻole pili i kēia mau lāʻau lapaʻau maʻamau.Ma muli o kāna hana hou aku e kūʻē iā Her2, ke noiʻi ʻia nei no ka maʻi maʻi umauma a me nā maʻi maʻi maʻi EGFR a me Her2 ʻē aʻe.3. He lāʻau lapaʻau ʻo Afatinib no ka lāʻau lapaʻau mua o nā maʻi me nā ʻano metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC).Hana ʻo ia ma ke ʻano he mea hiki ʻole ke hoʻololi i ka covalent inhibitor o ka receptor tyrosine kinases epidermal growth factor receptor (EGFR) a me erbB-2 (HER2).